[Pharmacologic bases of the treatment of coma in the diabetic patient].
D003681:Dehydration / Q000150:complications / Q000188:drug therapy*; D003926:Diabetic Coma / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000188:drug therapy* / Q000503:physiopathology; D005632:Fructose / Q000008:administration & dosage; D005934:Glucagon / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D007003:Hypoglycemia / Q000188:drug therapy* / Q000503:physiopathology; D007038:Hypotonic Solutions; D007275:Injections, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D000078790:Insulin Secretion; D007657:Ketone Bodies / Q000378:metabolism; D050356:Lipid Metabolism; D008297:Male; D010101:Oxygen Consumption; D011188:Potassium / Q000008:administration & dosage; D014867:Water / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D007038:Hypotonic Solutions; D007328:Insulin; D007657:Ketone Bodies; D014867:Water; D005632:Fructose; D006003:Glycogen; D005934:Glucagon; D005947:Glucose; D011188:Potassium
Les bases pharmacologiques du traitement du coma chez le diabétique.